G20 Health Minister’s Meeting concludes in Gandhinagar, Gujarat

Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting

Lupin acquires Boehringer Ingelheim's brands Ondero and Ondero Met to expand diabetes portfolio in India

This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes

Hikal receives Brazilian GMP certification and USFDA EIR for Bangalore and Panoli facilities

Honeywell, Recipharm to speed development of inhalers

Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs

Lupin Launches Tiotropium Dry Powder for Inhaler for COPD in US

Lupin actively contributes to alleviating the burden of COPD for patients across the nation

BioNTech appointing James Ryan as Chief Legal Officer

Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry

Cipla launches knowledge sharing platform ‘Ciplamed 2.0’

CiplaMed 2.0 leverages advanced analytics and automation

Pfizer receives USFDA approval for Elrexfio for the treatment of relapsed or refractory multiple myeloma

ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity

Parexel and Partex collaborate to leverage on AI and Big Data to accelerate drug delivery

Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets

Eugia Pharma receives USFDA Approval for Icatibant Injection

This is the 166th ANDA out of Eugia Pharma Speciality Group facilities